Metraipolis › archive › dc_68f888e56cbb
Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis — Europe PMC PMID:41499484
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41499484
- DOI
- 10.1172/jci.insight.196812
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T00:43:46.230Z
- SHA-256 of the archived text
6b54dd1421c16a0a46176be012b2c66100b710558da604085dbd1bfcd204278e- Stable URL of this page
https://metraipolis.com/documento/dc_68f888e56cbb
How to cite
Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis — Europe PMC PMID:41499484 — Europe PMC (en), https://europepmc.org/article/MED/41499484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68f888e56cbb (Metraipolis archive dc_68f888e56cbb, sha256 6b54dd1421c16a0a46176be012b2c66100b710558da604085dbd1bfcd204278e)
BibTeX
@misc{dc68f888e56cbb,
title = {Pathophysiological and therapeutic implications of C-type natriuretic peptide/cyclic GMP signaling in pulmonary fibrosis — Europe PMC PMID:41499484},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41499484},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68f888e56cbb; sha256 6b54dd1421c16a0a46176be012b2c66100b710558da604085dbd1bfcd204278e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41499484. Agents can read the archived copy with the MCP tool read_document.